Tel : 0086-021-5165-9050 / 0086-15618223367 Email : sales@atkchmemical.com
KPT 251
ATK-18508
98.00%
1388841-50-6
C14H7F6N5O
375.23
Article number Size Operate
ATK-18508 10MG 10MG Inquiry
ATK-18508 20MG 20MG Inquiry
Detection information
Purity: 99.99%
Product Details
CAS Number 1388841-50-6 Appearance
Catalog NO ATK-18508 MDL Number
Molecular Formula C14H7F6N5O Molecular Weight 375.23
Boiling Point Melting Point
Flash Poin Density
Synonyms KPT 251;KPT 251, >=98%;2-[(Z)-2-{3-[3,5-Bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}vinyl]-1,3,4-oxadiazole;KPT251;AOB6639;SCHEMBL11318201; AOB6639;myeloid leukemia,Apoptosis,KPT 251,Chromosomal Maintenance 1,CRM1,inhibit,Exportin 1,KPT-251,melanoma,XPO1,A375,Inhibitor,antileukemic activity;KPT-251;NSC773260;KPT251?;2-[(Z)-2-{3-[3,5-bis(trifluoromethyl)phenyl]-1h-1,2,4-triazol-1-yl}vinyl]-1,3,4-oxadiazole;AKOS027324202;HY-117996;EX-A9300;(Z)-2-{2-[3-(3,5-Bis-trifluoromethyl-phenyl)-[1,2,4]triazol-1-yl]-vinyl}-[1,3,4]oxadiazole;NCGC00351777-01;TS-08374;PD194909;DB-181772;(Z)-2-(2-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)vinyl)-1,3,4-oxadiazole;CS-0068815;2-[(Z)-2-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;LDFXTRYMMZGKIC-UPHRSURJSA-N;NSC-773260;1388841-50-6;F90220
Storage Condition
Safety
GHS Pictogram
Signal Word UN Number
Hazard Statements Class
Precautionary Statements Packing Group
Description
There is currently no product overview available!